1. Home
  2. MLEC vs KZIA Comparison

MLEC vs KZIA Comparison

Compare MLEC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • KZIA
  • Stock Information
  • Founded
  • MLEC 2008
  • KZIA 1994
  • Country
  • MLEC Cayman Islands
  • KZIA Australia
  • Employees
  • MLEC N/A
  • KZIA N/A
  • Industry
  • MLEC Blank Checks
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • KZIA Health Care
  • Exchange
  • MLEC Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • MLEC 10.1M
  • KZIA 9.0M
  • IPO Year
  • MLEC N/A
  • KZIA 1999
  • Fundamental
  • Price
  • MLEC $0.79
  • KZIA $7.12
  • Analyst Decision
  • MLEC
  • KZIA Strong Buy
  • Analyst Count
  • MLEC 0
  • KZIA 3
  • Target Price
  • MLEC N/A
  • KZIA $16.00
  • AVG Volume (30 Days)
  • MLEC 60.9K
  • KZIA 302.5K
  • Earning Date
  • MLEC 10-21-2025
  • KZIA 11-14-2025
  • Dividend Yield
  • MLEC N/A
  • KZIA N/A
  • EPS Growth
  • MLEC N/A
  • KZIA N/A
  • EPS
  • MLEC N/A
  • KZIA N/A
  • Revenue
  • MLEC N/A
  • KZIA $1,549,158.00
  • Revenue This Year
  • MLEC $20.42
  • KZIA N/A
  • Revenue Next Year
  • MLEC $30.00
  • KZIA $49.25
  • P/E Ratio
  • MLEC N/A
  • KZIA N/A
  • Revenue Growth
  • MLEC 170.36
  • KZIA 248983.08
  • 52 Week Low
  • MLEC $0.75
  • KZIA $2.86
  • 52 Week High
  • MLEC $10.47
  • KZIA $39.05
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 18.19
  • KZIA 44.01
  • Support Level
  • MLEC $0.88
  • KZIA $6.20
  • Resistance Level
  • MLEC $0.99
  • KZIA $8.00
  • Average True Range (ATR)
  • MLEC 0.09
  • KZIA 0.48
  • MACD
  • MLEC 0.03
  • KZIA -0.03
  • Stochastic Oscillator
  • MLEC 4.26
  • KZIA 49.73

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: